Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Federation Francophone de Cancerologie Digestive
Adult patients of both gender who have underwent surgical resection of stage III colorectal carcinoma and randomised to receive a chemotherapy FOLFOX or FOLFOX + Cetuximab in the PETACC8 trial.
Age
18–74
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient included in PETACC08 study
Signed informed consent for translational study
FFPE tumor sample available for CD3 staining
You may not be if
\- Patient who have withdrawn their consent for PETACC08 and/or for PETACC08 translational study
Clareo Health | Validation Study of Linear Quantification of CD3+ Cells in Localized Colorectal Carcinomas
